Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels
Aliment Pharmacol Ther
.
2023 Dec;58(11-12):1252-1253.
doi: 10.1111/apt.17760.
Authors
Jannis Kountouras
1
,
Evangelos Kazakos
1
2
,
Anthia Gatopoulou
3
,
Stergios A Polyzos
4
,
Maria Touloumtzi
1
,
Foteini Kyrailidi
1
,
Maria C Mouratidou
1
,
Aggeliki Stogianni
5
,
Elisabeth Vardaka
1
6
Affiliations
1
Department of Internal Medicine, Second Medical Clinic, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece.
2
School of Healthcare Sciences, Midwifery Department, University of West Macedonia, Kozani, Macedonia, Greece.
3
Second Department of Internal Medicine, General University Hospital of Alexandroupolis, Alexandroupolis, Greece.
4
First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece.
5
Department of Radiology, Ippokration Hospital, Thessaloniki, Macedonia, Greece.
6
Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, Thessaloniki, Macedonia, Greece.
PMID:
37986592
DOI:
10.1111/apt.17760
No abstract available
Publication types
Letter
Comment
MeSH terms
Alanine Transaminase
Carrier State
DNA, Viral
Hepatitis B e Antigens
Hepatitis B virus / genetics
Hepatitis B, Chronic*
Humans
Substances
Alanine Transaminase
DNA, Viral
Hepatitis B e Antigens